BR9809286A - Processos para redução de fibrinogênio - Google Patents

Processos para redução de fibrinogênio

Info

Publication number
BR9809286A
BR9809286A BR9809286-3A BR9809286A BR9809286A BR 9809286 A BR9809286 A BR 9809286A BR 9809286 A BR9809286 A BR 9809286A BR 9809286 A BR9809286 A BR 9809286A
Authority
BR
Brazil
Prior art keywords
reduction processes
fibrinogen
fibrinogen reduction
processes
reduction
Prior art date
Application number
BR9809286-3A
Other languages
English (en)
Inventor
Pamela W Anderson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9809286A publication Critical patent/BR9809286A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>"PROCESSOS PARA REDUçãO DE FIBRINOGêNIO"<D>. A invenção refere-se à redução de fibrinogênio em um ser humano por administração de um composto 2-aroil-3-arilbenzo [b] tiofeno.
BR9809286-3A 1997-04-22 1998-04-20 Processos para redução de fibrinogênio BR9809286A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22
PCT/US1998/007862 WO1998047365A1 (en) 1997-04-22 1998-04-20 Methods for reducing fibrinogen

Publications (1)

Publication Number Publication Date
BR9809286A true BR9809286A (pt) 2000-07-04

Family

ID=21933208

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809286-3A BR9809286A (pt) 1997-04-22 1998-04-20 Processos para redução de fibrinogênio

Country Status (23)

Country Link
US (1) US6025373A (pt)
EP (1) EP0878195B1 (pt)
JP (1) JP2001524101A (pt)
KR (1) KR20010012084A (pt)
CN (1) CN1254255A (pt)
AT (1) ATE219364T1 (pt)
AU (1) AU741720B2 (pt)
BR (1) BR9809286A (pt)
CA (1) CA2287196A1 (pt)
DE (1) DE69806098T2 (pt)
DK (1) DK0878195T3 (pt)
EA (1) EA002237B1 (pt)
ES (1) ES2178111T3 (pt)
HU (1) HUP0002727A3 (pt)
ID (1) ID22910A (pt)
IL (1) IL132504A0 (pt)
NO (1) NO995132L (pt)
NZ (1) NZ500389A (pt)
PL (1) PL336638A1 (pt)
PT (1) PT878195E (pt)
TR (1) TR199902605T2 (pt)
WO (1) WO1998047365A1 (pt)
ZA (1) ZA983298B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6353003B1 (en) * 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
ATE172623T1 (de) * 1991-12-17 1998-11-15 Dynamics Imaging Inc Verfahren und vorrichtung zur diagnose von lebenden organismen
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
CZ253694A3 (en) * 1993-10-15 1995-05-17 Lilly Co Eli Pharmaceutical preparation for treating resistant neoplasms
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
CN1173819A (zh) * 1995-02-06 1998-02-18 伊莱利利公司 抑制il－6作用的方法
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
ID22910A (id) 1999-12-16
DK0878195T3 (da) 2002-07-15
AU7250398A (en) 1998-11-13
HUP0002727A2 (hu) 2001-08-28
TR199902605T2 (xx) 2000-02-21
NO995132D0 (no) 1999-10-21
DE69806098T2 (de) 2003-01-02
EA199900959A1 (ru) 2000-06-26
NZ500389A (en) 2001-07-27
JP2001524101A (ja) 2001-11-27
ZA983298B (en) 1999-10-20
MX9909548A (es) 2003-02-27
EP0878195A1 (en) 1998-11-18
ES2178111T3 (es) 2002-12-16
PL336638A1 (en) 2000-07-03
KR20010012084A (ko) 2001-02-15
CN1254255A (zh) 2000-05-24
WO1998047365A1 (en) 1998-10-29
ATE219364T1 (de) 2002-07-15
IL132504A0 (en) 2001-03-19
PT878195E (pt) 2002-09-30
HUP0002727A3 (en) 2001-09-28
EP0878195B1 (en) 2002-06-19
NO995132L (no) 1999-10-21
DE69806098D1 (de) 2002-07-25
CA2287196A1 (en) 1998-10-29
AU741720B2 (en) 2001-12-06
US6025373A (en) 2000-02-15
EA002237B1 (ru) 2002-02-28

Similar Documents

Publication Publication Date Title
FR2768916B1 (fr) Agrafe d&#39;osteotomie tibiale
BR9712491A (pt) Composições cosméticas
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita&#39; analgesica
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
BR9914156A (pt) Formulação de 2-metil-tieno-benzodiazepina
BR9507771A (pt) Processos para preparação de ácido 1-Butil-2-(2&#39;-(2H-Tetratozol-5-IL)-Bifenil-4-Ilmetil(-1H-Indol-3-Carboxílico
SE9801494D0 (sv) Novel use
IT1302243B1 (it) Sintesi dell&#39;1,1,1,3,3-pentafluoropropano.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
PT1121375E (pt) Composto de elevada pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona
FR2796829B1 (fr) Plaque d&#39;osteotomie tibiale
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR9809439A (pt) Processos para preparação de benzotiofenos
IT1299990B1 (it) Lucchetto di sicurezza privo dell&#39;arco di collegamento.
ITMI931371A0 (it) Procedimento per la preparazione dell&#39;erdosteina
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
BR9712805A (pt) Processo para a preparação de compostos farmecêuticos
IT1288708B1 (it) Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell&#39;acne vulgaris.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1892 DE 10/04/2007.